Skip to main content
HCPCS A9606 · Level II · Part B drug

A9606: radium ra-223 dichloride, HCPCS Level II drug code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for A9606

Billing unit
1 microCurie
Radium ra223 dichloride ther
ASP payment limit
n/a
October 2026
Practitioner MUE
224
MAI 3
OPPS status
SI K
APC 1745
NCCI exposure
no PTP pairs
Coverage articles
1
7 states

TL;DR

HCPCS A9606 is the Level II code for Radium ra-223 dichloride, therapeutic, per microcurie, billed per 1 microCurie. The practitioner MUE allows up to 224 units per date of service (MAI 3). Under OPPS it carries status indicator K in APC 1745. A9606 is billed in units of 1 microCurie; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. 1 Medicare coverage article lists the code across 7 states, including A54559.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for A9606 at n/a per 1 microCurie for October 2026, derived from manufacturer average sales price plus 6%. Beneficiary coinsurance is 20%.

ASP payment limits for A9606
QuarterPayment limitPerCoinsurance
October 2026n/a1 microCurie20%
July 2026n/a1 microCurie—
CMS note: microCurie 100% AWP = $212.84 microCurie 100% WAC = $177.37

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk lists no NDC for A9606. Report the NDC from the product label and confirm the units conversion from the HCPCS descriptor (Radium ra-223 dichloride, therapeutic, per microcurie).

Medically Unlikely Edits (MUE)

CMS publishes 2 MUE values for A9606. For practitioners the limit is 224 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for A9606 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services2243 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital2243 Date of Service Edit: ClinicalPrescribing Information

MUE for A9606 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists A9606 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check A9606 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

A9606 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

1 current Medicare Administrative Contractor article lists A9606 in their HCPCS tables, covering 7 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing A9606
ArticleTitleContractor(s)StatesRelated LCD
A54559Billing and Coding: Xofigo Billing InstructionsPalmetto GBAAL GA NC SC TN VA WV—

Diagnoses Medicare contractors cover for A9606

One billing and coding article attaches a covered diagnosis list to A9606: 3 distinct ICD-10-CM codes in all. The 3 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 3 covered ICD-10-CM codes for A9606
ICD-10-CMDescription (FY2027)Articles covering
C61Malignant neoplasm of prostate1 of 1
C79.51Secondary malignant neoplasm of bone1 of 1
C79.52Secondary malignant neoplasm of bone marrow1 of 1

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to A9606 are counted here. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to A9606, by article
ArticleContractorGroups that applyCovered codes for A9606Full list
A54559Palmetto GBAone list for every code in the article3Open the list

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, A9606 carries status indicator K and is assigned to APC 1745, with a published national unadjusted payment of $180.422. Status K means the drug is paid separately under OPPS at the ASP-based rate rather than packaged into the procedure.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), A9606 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $180.42 per 1 microCurie, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for A9606 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for A9606

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS A9606

What does HCPCS code A9606 describe?

A9606 is defined by CMS as "Radium ra-223 dichloride, therapeutic, per microcurie". Each billing unit represents 1 microCurie, so the units reported on the claim must equal the dose administered divided by that unit.

Is A9606 a CPT code?

No. A9606 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as radium ra-223 dichloride; CPT codes are five-character codes maintained by the AMA. On a Part B claim A9606 reports the drug itself in 1 microcurie units, and the administration is billed on its own line.

How many units of A9606 can be billed per day?

The practitioner Medically Unlikely Edit is 224 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Does A9606 have NCCI bundling edits?

No active practitioner PTP pairs list A9606 as a column-1 or column-2 code in the v323r0 release.

Which Medicare coverage articles mention A9606?

1 current Billing and Coding Article in the Medicare Coverage Database lists A9606, covering 7 states: A54559 (Billing and Coding: Xofigo Billing Instructions).

What diagnosis codes support A9606?

One Medicare billing and coding article lists 3 covered ICD-10-CM codes for A9606, for example C61 (Malignant neoplasm of prostate); C79.51 (Secondary malignant neoplasm of bone); C79.52 (Secondary malignant neoplasm of bone marrow). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.